![](https://www.btig.com/wp-content/uploads/2022/06/medtech-digital-health.png?w=780)
BTIG MedTech, Digital Health, Life Science and Diagnostic Tools Conference
The BTIG MedTech, Digital Health, Life Science and Diagnostic Tools Conference took place on Tuesday, February 15th through Thursday, February 17, 2022. The event included company fireside chats and one-on-one meetings, where participants offered unique insights on their companies and the future growth of the healthcare industry. The conference was hosted by:
- Marie Thibault, BTIG Medical Technology and Digital Health Analyst
- Ryan Zimmerman, BTIG Medical Technology Analyst
- Sung Ji Nam, BTIG Life Science and Diagnostic Tools Analyst
- Mark Massaro, BTIG Life Science and Diagnostic Tools Analyst
- David Larsen, CFA, BTIG Healthcare IT and Digital Health Analyst
For more information about the conference, email [email protected]. To access BTIG insights, contact a firm representative or log in to www.btigresearch.com.
The conference was produced by BTIG’s Corporate Access program which hosts client events across the consumer, energy and infrastructure, financials, healthcare, real estate as well as technology, media, and telecommunications sectors.
This information was prepared for BTIG, LLC institutional clients. The information contained herein has been gathered from multiple sources and is believed to be reliable. However, BTIG, LLC has not independently verified the accuracy of the content and does not make any representations as to the accuracy or completeness of this information. The information is subject to change without notice and BTIG, LLC has no obligation to provide any updates or changes. BTIG, LLC is providing this data for informational purposes and does not believe that it is sufficient to base an investment decision on. This information should not be regarded as a solicitation or recommendation of any particular security or to engage in any trading strategy. BTIG, LLC does and may seek to do business, including investment banking and/or other capital markets business, with companies which are the subject of Corporate Access services.